A test known as the alpha-synuclein seed amplification assay, or alphaSyn-SAA, was able to measure the accumulation of alpha-synuclein protein…
Articles by Patricia Inácio, PhD
Researchers have developed analogs of cannabinol (CBN), a lesser-known cannabinoid, that show neuroprotective abilities in lab studies not…
Scientists exploring the potential of machine learning approaches in drug discovery for Parkinson’s disease and other neurodegenerative disorders —…
The Parkinson’s Foundation has joined forces with Tasso — a U.S. company that offers a sample collection and…
A three-week ketogenic diet, one low in carbohydrates and high in fat, supplemented with a specific type of fat —…
A Phase 1/2 clinical trial dubbed ASPIRO that’s testing Aspen Neuroscience’s ANPD001 — a stem cell therapy candidate designed…
Levels of two markers of intestinal inflammation — beta-defensin 2 and lactoferrin — were elevated in the stools of…
Among people in the early stages of Parkinson’s disease, a tool called trabecular bone score, or TBS, may help…
A test that uses skin biopsies was able to detect the form of alpha-synuclein protein that causes toxic clumps in…
Note: This story was updated March 27, 2024, to correct that the Michael J. Fox Foundation is not funding the…